Adlai Nortye (ANL) Stock Chart & Stock Price History → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free ANL Stock Alerts $7.26 -0.44 (-5.71%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Adlai Nortye Stock Price Performance5 Day Performance-30.86%1 Month Performance-44.20%3 Month Performance-8.10%6 Month Performance-31.44%Year-To-Date Performance-19.24% Receive ANL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide ANL Stock Chart for Saturday, June, 1, 2024 ANL Chart by TradingView Adlai Nortye Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$7.70$7.26-5.71%$8.37$6.7510,533 shs$267.89 million05/30/2024$8.26$7.70-6.78%$8.88$7.3062,758 shs$284.13 million05/29/2024$10.09$8.26-18.16%$10.70$8.2190,436 shs$304.79 million05/28/2024$10.50$10.09-3.88%$11.50$9.6018,760 shs$372.42 million05/27/2024$10.50$10.50$12.92$10.5017,700 shs$387.45 million05/24/2024$12.55$10.50-16.33%$12.92$10.5017,703 shs$387.45 million Get the Latest News and Ratings for ANL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$12.75$12.55-1.57%$13.92$11.7512,770 shs$463.10 million05/22/2024$12.75$12.75$12.75$12.75232 shs$470.48 million05/21/2024$12.75$12.75$12.75$12.75129 shs$470.48 million05/20/2024$13.25$12.75-3.77%$13.23$12.503,880 shs$470.48 million05/17/2024$13.90$13.25-4.68%$13.83$13.001,842 shs$488.93 million05/16/2024$13.92$13.90-0.14%$13.90$12.064,765 shs$512.91 million05/15/2024$13.00$13.92+7.08%$13.92$11.616,981 shs$513.65 million05/14/2024$13.00$13.00$13.00$11.496,634 shs$479.70 million05/13/2024$13.05$13.00-0.38%$13.25$11.794,026 shs$479.70 million05/10/2024$13.00$13.05+0.38%$13.51$12.604,900 shs$481.55 million05/09/2024$13.60$13.00-4.41%$13.43$12.733,855 shs$479.70 million05/08/2024$13.57$13.60+0.22%$13.60$13.60290 shs$501.84 million05/07/2024$12.73$13.57+6.60%$13.57$12.64834 shs$500.73 million05/06/2024$13.78$12.73-7.62%$13.80$12.677,267 shs$469.74 million05/03/2024$13.02$13.78+5.84%$13.79$13.403,247 shs$508.48 million05/02/2024$13.01$13.02+0.08%$14.12$11.811,064 shs$480.44 million05/01/2024$13.80$13.01-5.72%$14.13$12.605,159 shs$480.07 million04/30/2024$14.80$13.80-6.76%$13.83$13.311,923 shs$509.22 million04/29/2024$13.75$14.80+7.64%$14.90$13.523,552 shs$546.12 million04/26/2024$13.46$13.75+2.15%$13.75$12.038,145 shs$507.38 million04/25/2024$13.55$13.46-0.66%$13.55$12.604,531 shs$496.67 million04/24/2024$13.50$13.55+0.37%$13.55$12.208,059 shs$500.00 million04/23/2024$14.42$13.50-6.38%$14.20$11.4020,869 shs$498.15 million04/22/2024$12.40$14.42+16.29%$15.55$13.1535,510 shs$532.10 million04/19/2024$10.65$12.40+16.43%$12.45$10.3915,908 shs$457.56 million04/18/2024$10.53$10.65+1.14%$10.65$9.803,162 shs$392.99 million04/17/2024$10.53$10.53$10.53$9.574,332 shs$388.56 million04/16/2024$10.95$10.53-3.84%$10.75$9.007,508 shs$388.56 million04/15/2024$10.56$10.95+3.69%$11.20$10.219,059 shs$404.06 million04/12/2024$11.41$10.56-7.45%$11.47$10.553,726 shs$389.66 million04/11/2024$11.40$11.41+0.09%$11.64$10.8610,043 shs$421.03 million04/10/2024$10.80$11.40+5.56%$11.74$10.805,381 shs$420.66 million04/09/2024$12.32$10.80-12.34%$11.99$10.3123,503 shs$398.52 million04/08/2024$8.29$12.32+48.68%$17.48$10.54212,031 shs$454.61 millionOn June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$10.06$8.29-17.63%$11.13$7.657,806 shs$305.76 million04/04/2024$9.74$10.06+3.29%$10.19$9.515,874 shs$371.21 million04/03/2024$9.55$9.74+1.99%$9.74$9.552,308 shs$359.41 million04/02/2024$9.40$9.55+1.60%$9.60$9.154,501 shs$352.40 million04/01/2024$8.88$9.40+5.87%$9.40$8.904,413 shs$346.86 million03/29/2024$8.88$8.88-0.01%$8.88$8.88355 shs$327.63 million03/28/2024$9.14$8.88-2.84%$8.88$8.88355 shs$327.67 million03/27/2024$8.91$9.14+2.58%$9.14$9.14333 shs$337.27 million03/26/2024$8.55$8.91+4.21%$9.08$8.811,200 shs$328.78 million03/25/2024$9.03$8.55-5.32%$9.01$8.552,863 shs$315.50 million03/22/2024$8.51$9.03+6.11%$9.03$9.03283 shs$333.21 million03/21/2024$9.10$8.51-6.48%$9.10$8.511,767 shs$314.02 million03/20/2024$9.10$9.10$9.10$8.95544 shs$335.79 million03/19/2024$9.03$9.10+0.83%$9.10$8.95544 shs$335.79 million03/18/2024$9.00$9.03+0.28%$9.10$8.352,513 shs$333.02 million03/15/2024$9.01$9.00-0.11%$9.05$8.96631 shs$332.10 million03/14/2024$8.99$9.01+0.22%$9.01$8.621,409 shs$332.47 million03/13/2024$8.64$8.99+4.05%$8.99$8.841,040 shs$331.73 million03/12/2024$8.76$8.64-1.38%$8.86$8.341,687 shs$318.82 million03/11/2024$7.65$8.76+14.52%$8.76$8.681,156 shs$323.27 million03/08/2024$7.75$7.65-1.29%$7.65$7.15670 shs$282.29 million03/07/2024$7.55$7.75+2.65%$7.75$7.75461 shs$285.98 million03/06/2024$7.61$7.55-0.79%$8.00$7.55119 shs$278.60 million03/05/2024$8.10$7.61-6.05%$7.80$7.251,643 shs$280.81 million03/04/2024$7.90$8.10+2.53%$8.70$7.647,241 shs$298.89 million03/01/2024$7.15$7.90+10.49%$8.27$7.556,389 shs$291.51 million02/29/2024$7.15$7.15$7.15$7.15599 shs$263.84 million Related Companies: PepGen Stock Price Chart Applied Therapeutics Stock Price Chart Fulcrum Therapeutics Stock Price Chart Larimar Therapeutics Stock Price Chart Erasca Stock Price Chart Verve Therapeutics Stock Price Chart Corbus Pharmaceuticals Stock Price Chart Korro Bio Stock Price Chart Travere Therapeutics Stock Price Chart Oculis Stock Price Chart Receive ANL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANL) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.